Pharma sector Trump shock, Aurobindo Pharma broken by 2%
US President-elect Donald Trump crackdown prompted by pharmaceutical companies on Thursday in the domestic pharma market is seeing a sharp decline in stock. GlaxoSmithKline Pharma listed companies leave Nifty Index is a declining trend in all companies. Aurobindo Pharma declined by more than 2 per cent.
In addition Cadila 1.92 percent, 0.84 percent in Dr Reddy’s, Loopin 0.64 percent, Sun Pharma 1.02 per cent, 0.67 per cent, Glenmark, Divislab stocks fell 0.11 percent.
Share Market Tips–BUY RPPINFRA
Get commodity market updates from MCX HNI Tips and get free share market tips, contact at toll free no. 18003157801